FRI-179 Early and Week 52 biomarker (MRI-PDFF, ALT, MRE and PRO-C3) responses to resmetirompredict improvements in MASH and liver fibrosis

作者：Rohit Loomba, Rebecca Taub, Krishna Padmanabhan, Dominic Labriola, Mazen Noureddin, Naim Alkhouri · 发表于：Journal of Hepatology · 年份：2026 · DOI：10.1016/s0168-8278(26)01917-3 · 被引用次数：1 · 研究领域：Liver physiology and pathology、Liver Disease Diagnosis and Treatment、Liver Diseases and Immunity